|
E3 ligase Ligand-Linker Conjugates 14
|
E1021754-5mg
|
≥99% |
1957236-21-3 |
5mg
|
¥ 500.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
E3 ligase Ligand-Linker Conjugates 14
|
E1021754-50mg
|
≥99% |
1957236-21-3 |
50mg
|
¥ 1800.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
E3 ligase Ligand-Linker Conjugates 14
|
E1021754-25mg
|
≥99% |
1957236-21-3 |
25mg
|
¥ 1000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
E3 ligase Ligand-Linker Conjugates 14
|
E1021754-10mg
|
≥99% |
1957236-21-3 |
10mg
|
¥ 700.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
E3 ligase Ligand-Linker Conjugates 14
|
E1021754-100mg
|
≥99% |
1957236-21-3 |
100mg
|
¥ 2800.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
8-ethyl-1,3,6,7-tetramethyl-1H-imidazo[2,1-f]purine-2,4(3H,8H)-dione
|
E1016122-25mg
|
≥98% |
19970-45-7 |
25mg
|
¥ 2938.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(2-ethyl-1-piperidinyl)[4-(hydroxydiphenylmethyl)-2H-1,2,3-triazol-2-yl]-methanone
|
E1010075-1mg
|
|
2055172-43-3 |
1mg
|
¥ 3594.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Ethyl Tafluprostamide
|
E1009663-5mg
|
≥99% |
1185851-52-8 |
5mg
|
¥ 2100.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Ethyl Tafluprostamide
|
E1009663-10mg
|
≥99% |
1185851-52-8 |
10mg
|
¥ 3350.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(E)-metyl 2-((2-metoxy-5-(((2,4,6-trimetoxystyryl)sulfonyl)metyl)fenyl)amino) acetate
|
E1009063-5mg
|
|
592542-61-5 |
5mg
|
¥ 700.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(E)-metyl 2-((2-metoxy-5-(((2,4,6-trimetoxystyryl)sulfonyl)metyl)fenyl)amino) acetate
|
E1009063-50mg
|
|
592542-61-5 |
50mg
|
¥ 3200.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(E)-metyl 2-((2-metoxy-5-(((2,4,6-trimetoxystyryl)sulfonyl)metyl)fenyl)amino) acetate
|
E1009063-10mg
|
|
592542-61-5 |
10mg
|
¥ 1100.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(E)-metyl 2-((2-metoxy-5-(((2,4,6-trimetoxystyryl)sulfonyl)metyl)fenyl)amino) acetate
|
E1009063-100mg
|
|
592542-61-5 |
100mg
|
¥ 5000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Eflucimibe
|
E1007561-5mg
|
≥98% |
202340-45-2 |
5mg
|
¥ 3430.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Eflucimibe
|
E1007561-1mg
|
≥98% |
202340-45-2 |
1mg
|
¥ 1540.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Eflucimibe
|
E1007561-10mg
|
≥98% |
202340-45-2 |
10mg
|
¥ 5040.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
9-[(2E)-3-(2-Nitrophenyl)prop-2-EN-1-ylidene]-9H-fluorene
|
E1002536-5mg
|
≥99% |
4551-00-2 |
5mg
|
¥ 900.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
9-[(2E)-3-(2-Nitrophenyl)prop-2-EN-1-ylidene]-9H-fluorene
|
E1002536-50mg
|
≥99% |
4551-00-2 |
50mg
|
¥ 4900.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
9-[(2E)-3-(2-Nitrophenyl)prop-2-EN-1-ylidene]-9H-fluorene
|
E1002536-25mg
|
≥99% |
4551-00-2 |
25mg
|
¥ 3000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
9-[(2E)-3-(2-Nitrophenyl)prop-2-EN-1-ylidene]-9H-fluorene
|
E1002536-10mg
|
≥99% |
4551-00-2 |
10mg
|
¥ 1500.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1,3-Dihydro-4,5-bis(4-methoxyphenyl)-2H-imidazol-2-one
|
D997351-5mg
|
≥99% |
71727-40-7 |
5mg
|
¥ 3000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1,3-Dihydro-4,5-bis(4-methoxyphenyl)-2H-imidazol-2-one
|
D997351-1mg
|
≥99% |
71727-40-7 |
1mg
|
¥ 1300.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
1,3-Dihydro-4,5-bis(4-methoxyphenyl)-2H-imidazol-2-one
|
D997351-10mg
|
≥99% |
71727-40-7 |
10mg
|
¥ 4500.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
Drupanin
|
D997258-5mg
|
≥98% |
53755-58-1 |
5mg
|
¥ 3000.9
|
期货,请咨询 |
|
0 |
阿拉丁 |